Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: The sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT)

E. Meliga, H.M. Garcia-Garcia, M. Valgimigli, A. Chieffo, G. Biondi-Zoccai, A.O. Maree, N. Gonzalo, S. Cook, S. Marra, C. Moretti, S. De Servi, I.F. Palacios, S. Windecker, R. van Domburg, A. Colombo, I. Sheiban, P.W. Serruys
  • International Journal of Cardiology, September 2009, Elsevier
  • DOI: 10.1016/j.ijcard.2008.06.006

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.ijcard.2008.06.006

The following have contributed to this page: Prof. Giuseppe Biondi-Zoccai